IDEAS home Printed from https://ideas.repec.org/a/wly/soecon/v90y2024i3p701-740.html
   My bibliography  Save this article

CBD as a cure‐all? The impacts of state‐level legalization of prescription cannabidiol (CBD) on opioid prescriptions

Author

Listed:
  • Tim Bersak
  • Richard Gearhart
  • Nyakundi Michieka

Abstract

We investigate the impacts of state legalization of products containing cannabidiol (CBD), a non‐psychoactive alternative to marijuana, on opioid prescribing rates. Research suggests that legalized medical marijuana may reduce opioid prescriptions, though no empirical link between CBD and opioids has been ascertained. Using county‐level prescribing rates between 2010 and 2019, as well as state‐level morphine milligram equivalent (MME) consumption of 8 common opioids, we estimate that state adoption of limited access cannabis product (CBD) laws leads to no change in opioid prescribing rates. Using supply‐side access measures for access to CBD through legal and open dispensaries, we find that the ability to purchase CBD legally leads to 6.6% to 8.1% fewer opioid prescriptions at pre‐legalization means, which suggests that access to CBD products is essential when evaluating the impacts of legalization; synthetic control model estimates suggest that legal and open dispensaries reduce opioid prescribing rates by nearly 3.5% 2 years post‐legalization. We also find that mandating CBD be purchased with an ID or through a patient registry offsets most potential benefits of CBD legalization. Our results provide the first empirical evidence that: (i) state legalization of prescription CBD alone does not reduce opioid usage; (ii) regulations limiting purchasing, such as ID laws, negate nearly all of the benefits of demand‐side legalization; and (iii) supply‐side access, either via interstate purchasing or legal and open dispensaries, are vital in using pain‐management substances to fully combat the opioid epidemic.

Suggested Citation

  • Tim Bersak & Richard Gearhart & Nyakundi Michieka, 2024. "CBD as a cure‐all? The impacts of state‐level legalization of prescription cannabidiol (CBD) on opioid prescriptions," Southern Economic Journal, John Wiley & Sons, vol. 90(3), pages 701-740, January.
  • Handle: RePEc:wly:soecon:v:90:y:2024:i:3:p:701-740
    DOI: 10.1002/soej.12667
    as

    Download full text from publisher

    File URL: https://doi.org/10.1002/soej.12667
    Download Restriction: no

    File URL: https://libkey.io/10.1002/soej.12667?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Scott Cunningham & Manisha Shah, 2018. "Decriminalizing Indoor Prostitution: Implications for Sexual Violence and Public Health," The Review of Economic Studies, Review of Economic Studies Ltd, vol. 85(3), pages 1683-1715.
    2. A. Colin Cameron & Jonah B. Gelbach & Douglas L. Miller, 2008. "Bootstrap-Based Improvements for Inference with Clustered Errors," The Review of Economics and Statistics, MIT Press, vol. 90(3), pages 414-427, August.
    3. Powell, David & Pacula, Rosalie Liccardo & Jacobson, Mireille, 2018. "Do medical marijuana laws reduce addictions and deaths related to pain killers?," Journal of Health Economics, Elsevier, vol. 58(C), pages 29-42.
    4. Eduardo Cavallo & Sebastian Galiani & Ilan Noy & Juan Pantano, 2013. "Catastrophic Natural Disasters and Economic Growth," The Review of Economics and Statistics, MIT Press, vol. 95(5), pages 1549-1561, December.
    5. Callaway, Brantly & Sant’Anna, Pedro H.C., 2021. "Difference-in-Differences with multiple time periods," Journal of Econometrics, Elsevier, vol. 225(2), pages 200-230.
    6. Djogbenou, Antoine A. & MacKinnon, James G. & Nielsen, Morten Ørregaard, 2019. "Asymptotic theory and wild bootstrap inference with clustered errors," Journal of Econometrics, Elsevier, vol. 212(2), pages 393-412.
    7. Thomas C. Buchmueller & Colleen Carey, 2018. "The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare," American Economic Journal: Economic Policy, American Economic Association, vol. 10(1), pages 77-112, February.
    8. Saffer, Henry & Chaloupka, Frank, 1999. "The Demand for Illicit Drugs," Economic Inquiry, Western Economic Association International, vol. 37(3), pages 401-411, July.
    9. Abadie, Alberto & Diamond, Alexis & Hainmueller, Jens, 2010. "Synthetic Control Methods for Comparative Case Studies: Estimating the Effect of California’s Tobacco Control Program," Journal of the American Statistical Association, American Statistical Association, vol. 105(490), pages 493-505.
    10. Wen, Hefei & Hockenberry, Jason M. & Cummings, Janet R., 2015. "The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances," Journal of Health Economics, Elsevier, vol. 42(C), pages 64-80.
    11. Crost, Benjamin & Guerrero, Santiago, 2012. "The effect of alcohol availability on marijuana use: Evidence from the minimum legal drinking age," Journal of Health Economics, Elsevier, vol. 31(1), pages 112-121.
    12. Alberto Abadie & Alexis Diamond & Jens Hainmueller, 2015. "Comparative Politics and the Synthetic Control Method," American Journal of Political Science, John Wiley & Sons, vol. 59(2), pages 495-510, February.
    13. Sebastian Galiani & Brian Quistorff, 2017. "The synth runner package: Utilities to automate synthetic control estimation using synth," Stata Journal, StataCorp LLC, vol. 17(4), pages 834-849, December.
    14. Noémi Kreif & Richard Grieve & Dominik Hangartner & Alex James Turner & Silviya Nikolova & Matt Sutton, 2016. "Examination of the Synthetic Control Method for Evaluating Health Policies with Multiple Treated Units," Health Economics, John Wiley & Sons, Ltd., vol. 25(12), pages 1514-1528, December.
    15. Rhet A. Smith, 2020. "The Effects Of Medical Marijuana Dispensaries On Adverse Opioid Outcomes," Economic Inquiry, Western Economic Association International, vol. 58(2), pages 569-588, April.
    16. Frank J. Chaloupka & Adit Laixuthai, 1997. "Do Youths Substitute Alcohol and Marijuana? Some Econometric Evidence," Eastern Economic Journal, Eastern Economic Association, vol. 23(3), pages 253-276, Summer.
    17. D. Mark Anderson & Daniel I. Rees, 2014. "The Role of Dispensaries: The Devil is in the Details," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 33(1), pages 235-240, January.
    18. Benjamin Hansen & Keaton Miller & Caroline Weber, 2020. "Early Evidence On Recreational Marijuana Legalization And Traffic Fatalities," Economic Inquiry, Western Economic Association International, vol. 58(2), pages 547-568, April.
    19. Rosalie L. Pacula & David Powell & Paul Heaton & Eric L. Sevigny, 2015. "Assessing the Effects of Medical Marijuana Laws on Marijuana Use: The Devil is in the Details," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 34(1), pages 7-31, January.
    20. Pacula, Rosalie Liccardo, 1998. "Does increasing the beer tax reduce marijuana consumption?," Journal of Health Economics, Elsevier, vol. 17(5), pages 557-585, October.
    21. David Powell & Rosalie Liccardo Pacula, 2021. "The Evolving Consequences of OxyContin Reformulation on Drug Overdoses," American Journal of Health Economics, University of Chicago Press, vol. 7(1), pages 41-67.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Cameron M. Ellis & Martin F. Grace & Rhet A. Smith & Juan Zhang, 2022. "Medical cannabis and automobile accidents: Evidence from auto insurance," Health Economics, John Wiley & Sons, Ltd., vol. 31(9), pages 1878-1897, September.
    2. Chu, Yu-Wei Luke & Townsend, Wilbur, 2019. "Joint culpability: The effects of medical marijuana laws on crime," Journal of Economic Behavior & Organization, Elsevier, vol. 159(C), pages 502-525.
    3. Michele Baggio & Alberto Chong & Sungoh Kwon, 2020. "Marijuana and alcohol: Evidence using border analysis and retail sales data," Canadian Journal of Economics/Revue canadienne d'économique, John Wiley & Sons, vol. 53(2), pages 563-591, May.
    4. Christian Gunadi, 2022. "Does expanding access to cannabis affect traffic crashes? County‐level evidence from recreational marijuana dispensary sales in Colorado," Health Economics, John Wiley & Sons, Ltd., vol. 31(10), pages 2244-2268, October.
    5. Sabia, Joseph J. & Dave, Dhaval & Alotaibi, Fawaz & Rees, Daniel I., 2024. "The effects of recreational marijuana laws on drug use and crime," Journal of Public Economics, Elsevier, vol. 234(C).
    6. Denti, Daria & Iammarino, Simona, 2022. "Coming Out of the Woods. Do local support services influence the propensity to report sexual violence?," Journal of Economic Behavior & Organization, Elsevier, vol. 193(C), pages 334-352.
    7. Carrieri, Vincenzo & Madio, Leonardo & Principe, Francesco, 2020. "Do-It-Yourself medicine? The impact of light cannabis liberalization on prescription drugs," Journal of Health Economics, Elsevier, vol. 74(C).
    8. Anderson, D. Mark & Rees, Daniel I., 2021. "The Public Health Effects of Legalizing Marijuana," IZA Discussion Papers 14292, Institute of Labor Economics (IZA).
    9. Petrova, Olga & Gray, Natallia, 2021. "The effects of medical marijuana laws on birth outcomes: Evidence from early adopting U.S. states," Economic Analysis and Policy, Elsevier, vol. 69(C), pages 68-82.
    10. Weiwei Chen & Michael T. French, 2023. "Marijuana legalization and traffic fatalities revisited," Southern Economic Journal, John Wiley & Sons, vol. 90(2), pages 259-276, October.
    11. Antonios M. Koumpias & Charles Courtemanche & Jordan W. Jones & Daniela Zapata, 2024. "Revisiting the connection between state Medicaid expansions and adult mortality," Southern Economic Journal, John Wiley & Sons, vol. 91(1), pages 187-212, July.
    12. Smart, Rosanna & Doremus, Jacqueline, 2023. "The kids aren’t alright: The effects of medical marijuana market size on adolescents," Journal of Health Economics, Elsevier, vol. 87(C).
    13. Bruno Ferman & Cristine Pinto & Vitor Possebom, 2020. "Cherry Picking with Synthetic Controls," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 39(2), pages 510-532, March.
    14. Borbely, Daniel & Lenhart, Otto & Norris, Jonathan & Romiti, Agnese, 2022. "Marijuana Legalization and Mental Health," IZA Discussion Papers 15729, Institute of Labor Economics (IZA).
    15. Chakraborty Avinandan & Doremus Jacqueline & Stith Sarah, 2021. "The effects of recreational cannabis access on labor markets: evidence from Colorado," IZA Journal of Labor Economics, Sciendo & Forschungsinstitut zur Zukunft der Arbeit GmbH (IZA), vol. 10(1), pages 1-86, January.
    16. Amos Z. B. Flomo & Elissaios Papyrakis & Natascha Wagner, 2023. "Evaluating the economic effects of the Ebola virus disease in Liberia: A synthetic control approach," Journal of International Development, John Wiley & Sons, Ltd., vol. 35(6), pages 1478-1504, August.
    17. Anna Choi & Dhaval Dave & Joseph J. Sabia, 2019. "Smoke Gets in Your Eyes: Medical Marijuana Laws and Tobacco Cigarette Use," American Journal of Health Economics, MIT Press, vol. 5(3), pages 303-333, Summer.
    18. Abby Alpert & David Powell & Rosalie Liccardo Pacula, 2018. "Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids," American Economic Journal: Economic Policy, American Economic Association, vol. 10(4), pages 1-35, November.
    19. Andreyeva Elena & Ukert Benjamin, 2019. "The Impact of Medical Marijuana Laws and Dispensaries on Self-Reported Health," Forum for Health Economics & Policy, De Gruyter, vol. 22(2), pages 1-20, December.
    20. Hollingsworth, Alex & Wing, Coady, 2020. "Tactics for design and inference in synthetic control studies: An applied example using high-dimensional data," SocArXiv fc9xt, Center for Open Science.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wly:soecon:v:90:y:2024:i:3:p:701-740. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: https://doi.org/10.1002/(ISSN)2325-8012 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.